Evidence map›Paper›PMID 42228276›Full record

ArticleHealth economics review2026

The Spanish transplantation model as a benchmark: clinical, societal, and economic impact of liver transplants in Spain (1984-2024).

Edson Plasencia Sánchez, Concepción Gómez Gavara, Glòria Merino Pinto, Roger Sabater Mezquita, Itxarone Bilbao, Gerardo Blanco-Fernández, Gloria de la Rosa, Gemma Piella

Abstract read
In one paragraph

Article in Health economics review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Edson Plasencia SánchezSIMBIOsys Group, Department of Engineering, Universitat Pompeu Fabra, Carrer de Tanger 122, Barcelona, 08018, Spain.ORCID http://orcid.org/0000-0002-3894-5320
Concepción Gómez GavaraDepartment of Hepatic and Biliary Surgery and Transplants, Hospital Universitari Vall d'Hebron, Pg. Vall d'Hebron 119, Barcelona, 08035, Spain. concepcion.gomez@vallhebron.cat.ORCID http://orcid.org/0000-0001-8312-3273
Glòria Merino PintoCentre de Recerca en Economia i Salut, Departament d'Economia i Empresa, Universitat Pompeu Fabra, Barcelona, 08005, Spain.ORCID http://orcid.org/0009-0008-9705-0691
Roger Sabater MezquitaCentre de Recerca en Economia i Salut, Departament d'Economia i Empresa, Universitat Pompeu Fabra, Barcelona, 08005, Spain.ORCID http://orcid.org/0009-0002-5387-5436
Itxarone BilbaoDepartment of Hepatic and Biliary Surgery and Transplants, Hospital Universitari Vall d'Hebron, Pg. Vall d'Hebron 119, Barcelona, 08035, Spain.ORCID http://orcid.org/0000-0002-7389-395X
Gerardo Blanco-FernándezSociedad Española de Trasplante Hepático (SETH), Madrid, Spain.ORCID http://orcid.org/0000-0003-4845-5306
Gloria de la RosaOrganización Nacional de Trasplantes (ONT), Ministerio de Sanidad, Madrid, Spain.ORCID http://orcid.org/0000-0002-5253-3234
Gemma PiellaSIMBIOsys Group, Department of Engineering, Universitat Pompeu Fabra, Carrer de Tanger 122, Barcelona, 08018, Spain. gemma.piella@upf.edu.ORCID http://orcid.org/0000-0001-5236-5819

Funding

Maria de Maeztu Units of Excellence Programme CEX2021-001195-M
6 · The paper itself

Abstract

Spain leads the world in organ donation, and the 40th anniversary of its first liver transplant was recently commemorated. Our aim was to evaluate the evolution of the Liver Transplantation (LT) program in Spain over its four decades (1984-2024), examining clinical outcomes and societal economic benefits within a mature transplantation framework. Standardized national data from the Organización Nacional de Trasplantes and the Sociedad Española de Trasplante Hepático were used to reconstruct recipient cohorts by age group. Patient survival was estimated using Kaplan-Meier analysis. An economic evaluation from a societal perspective integrated surgical costs, long-term immunosuppressive therapy, and productivity gains associated with recipients' participation in the labour market. LT activity increased steadily during the initial expansion of the program and has stabilised at approximately 1,200 procedures per year over the past two decades. Both donor and recipient populations have aged; there are currently more patients over 60 years of age than two decades ago. Survival improved throughout the study period, extending life expectancy despite variations related to underlying disease. From an economic perspective, annual surgical costs remained below €60 million, increasing to €70-90 million when long-term immunosuppressive therapy was included. The economic contribution of surviving recipients to the labour market increased steadily, exceeding €75 million in 2024 and resulting in a positive balance since the early 2010s. Adult recipients generated net economic benefits, whereas paediatric recipients showed delayed but progressively increasing contributions as they entered the workforce. LT in Spain has produced sustained improvements in expected survival while generating substantial societal value, demonstrating that LT is both an effective clinical intervention and a valuable public health investment. The Spanish liver transplantation system may serve as a benchmark for evaluating the sustainability and societal impact of liver transplant programs in other healthcare systems.

Indexed as

Economic impactHealth EconomicsLiver transplantationSocietal valueSpain

Identifiers

PMID42228276
PMCPMC13465184

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.